Breaking News
Investing Pro 0
🚨 NDVA surged 43%. This AI Chipmaker Could Be Next See Analysis
Close

AstraZeneca PLC (AZNs)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,593.75 0.00    0.00%
08/06 - Closed. Currency in SEK ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1,590.00 - 1,594.50
Type:  Equity
Market:  Euro Zone
ISIN:  GB0009895292 
AstraZeneca 1,593.75 0.00 0.00%

AZNs Cash Flow Statement

 
Featured here, the Cash Flow Statement for AstraZeneca PLC, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Period Ending: 2023
31/03
2022
31/12
2022
30/09
2022
30/06
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line 1803 901 1641 360
Cash From Operating Activities 3133 2398 2930 1248
Depreciation/Depletion 260 1256 1308 283
Amortization 971 - - 1006
Deferred Taxes - - - -
Non-Cash Items -143 -58 -1086 -988
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 225 288 329 778
Cash Interest Paid 257 241 222 192
Changes in Working Capital 242 299 1067 587
Cash From Investing Activities -1246 -249 -1743 -800
Capital Expenditures -247 -372 -247 -253
Other Investing Cash Flow Items, Total -999 123 -1496 -547
Cash From Financing Activities -2031 -358 -1430 -1295
Financing Cash Flow Items -840 - -50 -
Total Cash Dividends Paid -3047 - -1393 -
Issuance (Retirement) of Stock, Net 4 18 3 3
Issuance (Retirement) of Debt, Net 1852 -376 10 -1298
Foreign Exchange Effects - - - -
Net Change in Cash -155 1797 -294 -873
Beginning Cash Balance 6387 4369 4752 5690
Ending Cash Balance 6232 6166 4458 4817
Free Cash Flow 2397.25 2355.5 1546.38 1583.75
Free Cash Flow Growth -25.27 52.32 -2.36 -68.79
Free Cash Flow Yield 0.888 0.876 1.1 0.382
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oct 28, 2021 0:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Double top in reach
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email